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Abstracts
care integrating multiple measures of both resource use and clinical outcomes. Contemporary performance assessment technology only evaluates one outcome measure at a time and does not consider resource use. METHODS: The basis for comparison is the technical efficiency with which providers transform resources into outcomes relative to peers. By identifying the highest level of performance-the efficiency frontier-the relative efficiency of each provider under evaluation is quantified. Relative efficiency is determined among diabetes care teams at Steno Diabetes Center, Denmark, over a 6-year period (1995) (1996) (1997) (1998) (1999) (2000) . Applied outcome measures follow recommendations of the Diabetes Quality Improvement Project and resources include clinical tests and patient care time of physicians, nurses and dieticians. Data Envelopment Analysis (DEA), a linear programming optimization technique, estimates relative efficiency, while regression analysis (RA) examines the robustness of the method. Impact of case-mix differences is examined by subgroup analysis. RESULTS: Over the study period, DEA identified a total of four teams on the frontier for clinical tests and ten teams for patient care time. Below frontier practice implied a 7% excess use of HbA1c tests, 12% blood pressure tests and 22% lipid measurements and 6% physician, 5% nurse and 13% dietician care time. Subgroup estimates implied less variation across teams and up to 30% reduction in predicted excess use of resources. When adjusting for clinical outcomes, RA identified an excess use of resources among the same teams operating below frontier in DEA. CONCLU-SIONS: The method appears robust in identifying performance below frontier set by peers and a useful diagnostic tool for identifying efficiency gaps and setting targets for performance improvement in diabetes care. Identification of major subgroups in outcomes and resource use is important for practical implementation of the method. 
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DEVELOPMENT OF A WEB-BASED SURVEY TO DETERMINE PRACTICE PATTERNS FOR TREATMENT OF ADVANCED STAGE BREAST CANCER IN FIVE EUROPEAN COUNTRIES
OBJECTIVES:
Although breast cancer is highly prevalent and the third leading cause of mortality for women in Europe, little is known about treatment patterns for women with this disease. Intra-or cross-country comparisons of treatment patterns are difficult due to the absence of automated data systems that capture clinical or health care claims records for representative population samples. To overcome this barrier, we designed and developed a web-based study to determine patterns of care in advanced stage breast cancer for France, England, Italy, Spain, and Germany. METHODS: The study includes three components: 1) survey design and validation; 2) web-translation of the survey; and 3) identification and recruitment of physicians to complete the survey. Survey Design: Country-specific and international treatment guidelines were collated into a comprehensive list of management strategies. The survey is grouped into categories: Initial evaluation; initial therapy; second and third-line treatment; monitoring; supportive care. Web Translation: The web site is designed to elicit specific answers rather than open responses. Drop down lists and check boxes facilitate completion. "Yes" answers to specific questions ("Chemotherapy is indicated: Yes/No") direct the respondent to more detailed questions on the topic. Respondents log in with a secure ID/password, and can enter and exit as many times as is needed. Physician Recruitment: Physician key opinion leaders (KOLs) with expertise in breast cancer are recruited from each country (stratified by service area) in three separate phases. RESULTS: In Phase I, KOLs review the "beta" web site, offering suggestions for improving its accuracy and comprehensiveness. In Phase II, a new group of KOLs complete the survey from their home or office. In Phase III, KOLs from Phase I review the summary results and comment on the findings. CONCLUSIONS: Although subject to certain limitations, the web-based survey offers an efficient strategy to determine practice patterns for advanced breast cancer.
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DATA ACQUISITION AND INTEGRATION FOR ANTIBIOTIC TREATMENT REPORTING
Haase M 1 , Sasaki P 1 , Fazio J 2 1 Strong Square, LLC, Kirkland, WA, USA; 2 Northwest Pharmacy Services, Portland, OR, USA OBJECTIVES: Develop a database tool to allow the administration, acquisition and integration of disparate medical, pharmacy, enrollment, and provider-specific data to measure adherence to a regional antibiotic treatment guideline program. Critical, innovative data management and patient confidentiality measures were developed and implemented to build a unified data set of antibiotic prescribing episodes. METHODS: Strong Square, LLC incorporated the medical, pharmacy and professional claims from seven participating health plans in Washington state to create an integrated database of patient-specific longitudinal data. This database was used to measure the impact of previously distributed antibiotic prescribing guidelines. Recent U.S. Federal regulations (HIPAA) require non-disclosure of patient-specific data and additional reporting limitations imposed by participating health plans submitting data required that all personal-identifiers be masked. To address this, Strong Square, LLC developed a cipher application that masks all personal identifiers without hindering the ability to
